Adverse Event reporting information can be found in footer
Request a Meeting
DesmoMelt is well accepted by children of various ages and facilitates early intervention2, providing an effective and convenient solution to PNE and helping children and families return to a normal life.
A statistically significant preference for DesmoMelt has been shown in children aged 5-11 years2. (For patients
<12 years, 60.6% patients preferred the melt formulation [p=0.009])2
Compared with tablets, DesmoMelt provides a significantly superior antidiuretic effect and concentrating capacity 3-8 hours after dosing3.
The probability of a reduction in bedwetting episodes is twice as likely with DesmoMelt4
Tablet consumption may require 60 mL of water (approximately a quarter of the expected bladder capacity of a 7 year old) which may also impact the efficacy of desmopressin4.
A single dose (120mcg) of DesmoMelt should be taken before bedtime for a period of 3 months, followed by a one-week drug-free period to assess results. If symptoms persist, the treatment cycle should be repeated1.
For more information about the benefits of DesmoMelt, download our short leaflet.
Job Code: UK-MN-2200029 - Date of preparation: March 2023